RxDoctor Payments Data

Barry Leber

Neurology · Clearwater, FLNPI 1386757110

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.5% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Acadia Pharmaceuticals Inc at 24.2% of the total. Reporting peaked in 2019 at $1,007 and has fallen 88.5% since, to $115 in 2021. That places this record below the midpoint for neurology clinicians in FL, where the typical reported total is $1,698.

$1,937in general payments, 2019–2025

Across 129 payments — averaging $15.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$469
  • UCB, Inc.$239
  • Sanofi$218
  • Novartis$193
  • Teva Pharmaceuticals USA, Inc.$156
  • AbbVie$121
  • plus $541 from 15 others

What the payments were for

  • Speaking & faculty fees$482%
  • Food & beverage$1,88998%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,937 in reported general payments places this provider in the 50th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Other neurology in Clearwater

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →